MK-677 50 mg

$80.00

    Purity > 99% – View Lab Test

  • CompoundMK-677 (Ibutamoren)
  • Amount50 mg per vial
  • FormLyophilized powder
  • Purity≥99% (HPLC COA available)
  • ManufactureGMP-certified facility
  • Storage (dry)Cool, dry place
  • After reconstitution2–8 °C (short-term); ?20 °C for long-term

Out of stock

Description

MK-677 (Ibutamoren) 50 mg — Oral GH Secretagogue & Ghrelin-Receptor Agonist for Research

MK-677 (Ibutamoren) is a non-peptide small-molecule
growth hormone secretagogue that acts as an agonist at the
ghrelin (GHS-R1a) receptor. In preclinical and human research, MK-677 has been
investigated for its ability to increase endogenous growth hormone (GH) and IGF-1
levels and for exploratory effects on body composition, sleep, and metabolic markers.

What It Is

  • Class: Non-peptide GH secretagogue / ghrelin-receptor agonist
  • Target: Growth hormone secretagogue receptor (GHS-R1a), related to endogenous ghrelin
  • Research focus: GH/IGF-1 axis, body composition, appetite, and metabolic endpoints

Proposed Mechanisms (Preclinical)

Ghrelin Receptor & GH/IGF-1 Axis

  • Acts as an agonist at GHS-R1a, mimicking ghrelin at pituitary and hypothalamic sites.
  • Stimulates pulsatile GH release in experimental models and human studies.
  • Leads to secondary increases in IGF-1 and related downstream anabolic markers.

Appetite, Body Composition & Metabolism

  • Associated with increased appetite and caloric intake in many research settings.
  • Explored for effects on lean mass, fat mass, and functional outcomes in selected cohorts.
  • Model-dependent changes in glucose handling, lipids, and bone-turnover markers have been reported.

Selected Research Highlights

  • GH/IGF-1 Enhancement: MK-677 has been studied for sustained elevations
    of GH and IGF-1 with oral administration in both animal and human trials.
  • Body-Composition Research: Experimental work has examined
    lean mass, fat mass, and muscle function as exploratory endpoints.
  • Sleep & Neuroendocrine Effects: Some studies report changes in
    sleep architecture and neuroendocrine parameters, consistent with ghrelin-pathway engagement.
  • Aging & Catabolic States: Investigated in models of aging, immobilization,
    or catabolic stress for potential impacts on GH-axis and body-composition markers.

Chemical & Handling Information

  • Type: Non-peptide small-molecule ghrelin-receptor agonist
  • Form: Lyophilized powder for laboratory reconstitution
  • Appearance: White to off-white powder

Specifications

  • Compound: MK-677 (Ibutamoren)
  • Amount: 50 mg per vial
  • Form: Lyophilized powder
  • Purity: ?99% (HPLC); COA per lot available
  • Packaging: Sealed vials suitable for standard laboratory handling

Storage & Stability

  • Store lyophilized vials in a cool, dry place, protected from light and moisture.
  • Refrigeration or freezing of the lyophilized compound is recommended for extended stability,
    according to laboratory SOPs.
  • After reconstitution, store at 2–8 °C for short-term use.
  • For long-term storage, aliquot and freeze at ?20 °C or below; avoid repeated freeze–thaw cycles.

Reviews

There are no reviews yet.

Be the first to review “MK-677 50 mg”

Your email address will not be published. Required fields are marked *